Latest news
Rapport Therapeutics Reports Second Quarter 2026 Financials and Provides Business Update - GlobeNewswireGlobeNewswire · Wed, 05 Aug 2026 11:00:00 GMTGrace Therapeutics Announces $10 Million Private Placement - The Manila TimesThe Manila Times · Wed, 05 Aug 2026 01:12:41 GMTGrace Therapeutics Announces $10 Million Private Placement Financing to Support GTx-104 Development - Quiver QuantitativeQuiver Quantitative · Wed, 05 Aug 2026 01:10:00 GMTPfizer axes ex-Metsera obesity asset and GIPR prospect in quarterly clearout - Fierce BiotechFierce Biotech · Tue, 04 Aug 2026 12:47:33 GMTViking Therapeutics Widens Loss to $128 Million as It Pushes Obesity Drugs Toward Market - finance.biggo.comfinance.biggo.com · Thu, 30 Jul 2026 05:34:53 GMTViking Therapeutics Q2 Earnings Call Highlights - TradingViewTradingView · Thu, 30 Jul 2026 01:04:00 GMTGrace Therapeutics Receives Type a Meeting Minutes from FDA and Provides Update on GTx-104 Clinical-Stage Injectable Formulation - marketscreener.commarketscreener.com · Tue, 28 Jul 2026 13:08:20 GMTGrace Therapeutics Announces Receipt of Type A Meeting Minutes from U.S. Food and Drug Administration - The Manila TimesThe Manila Times · Tue, 28 Jul 2026 11:15:35 GMT